Erythropoietin protects against diabetes through direct effects on pancreatic β cells

Journal of Experimental Medicine

Volumn 207, Issue 13, 2010, Pages 2831-2842

  Choi, Diana ^a,b   Schroer, Stephanie A ^b   Lu, Shun Yan ^b   Wang, Linyuan ^a,b   Wu, Xiaohong ^b   Liu, Yunfeng ^a   Zhang, Yi ^a   Gaisano, Herbert Y ^a   Wagner, Kay Uwe ^c,d   Wu, Hong ^e   Retnakaran, Ravi ^a,b,f   Woo, Minna ^a,b,g,h  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MOUNT SINAI HOSPITAL   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

^h ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN RECEPTOR; JANUS KINASE 2; RECOMBINANT ERYTHROPOIETIN; STAT5 PROTEIN; STREPTOZOCIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; EX VIVO STUDY; GENE CONTROL; GLUCOSE HOMEOSTASIS; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; BLOTTING, WESTERN; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-SECRETING CELLS; JANUS KINASE 2; KI-67 ANTIGEN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ERYTHROPOIETIN; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78650397022     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20100665     Document Type: Article

References (54)

1. Allison, J., H.E. Thomas, T. Catterall, T.W. Kay, and A. Strasser. 2005. Transgenic expression of dominant-negative Fas-associated death domain protein in beta cells protects against Fas ligand-induced apoptosis and reduces spontaneous diabetes in nonobese diabetic mice. J. Immunol. 175:293-301.
2. Bach, J.F. 1994. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15:516-542.
3. Bernal-Mizrachi, E., W. Wen, S. Stahlhut, C.M. Welling, and M.A. Permutt. 2001. Islet beta cell expression of constitutively active Akt1/ PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J. Clin. Invest. 108:1631-1638.
4. Bernal-Mizrachi, E., S. Fatrai, J.D. Johnson, M. Ohsugi, K. Otani, Z. Han, K.S. Polonsky, and M.A. Permutt. 2004. Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J. Clin. Invest. 114:928-936.
5. Bittorf, T., J. Seiler, B. Ludtke, T. Buchse, R. Jaster, and J. Brock. 2000. Activation of STAT5 during EPO-directed suppression of apoptosis. Cell. Signal. 12:23-30. doi:10.1016/S0898-6568(99)00063-7 (Pubitemid 30017965)
6. Brines, M., and A. Cerami. 2006. Discovering erythropoietin's extrahematopoietic functions: biology and clinical promise. Kidney Int. 70:246-250. doi:10.1038/sj.ki.5001546 (Pubitemid 44086573)
7. Cousin, S.P., S.R. Hugl, M.G. Myers Jr., M.F. White, A. Reifel-Miller, and C.J. Rhodes. 1999. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling. Biochem. J. 344:649-658. doi:10.1042/0264-6021:3440649 (Pubitemid 30036999)
8. Craig, K.J., J.D. Williams, S.G. Riley, H. Smith, D.R. Owens, D. Worthing, I. Cavill, and A.O. Phillips. 2005. Anemia and diabetes in the absence of nephropathy. Diabetes Care. 28:1118-1123. doi:10.2337/ diacare.28.5.1118
9. Damen, J.E., L. Liu, R.L. Cutler, and G. Krystal. 1993. Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein. Blood. 82:2296-2303. (Pubitemid 23304251)
10. DeFronzo, R.A. 1997. Pathogenesis of type 2 diabetes mellitus: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev. 5:177-269.
11. Depping, R., K. Kawakami, H. Ocker, J.M. Wagner, M. Heringlake, A. Noetzold, H.H. Sievers, and K.F. Wagner. 2005. Expression of the erythropoietin receptor in human heart. J. Thorac. Cardiovasc. Surg. 130:877-878. doi:10.1016/j.jtcvs.2004.12.041 (Pubitemid 41265735)
12. Digicaylioglu, M., S. Bichet, H.H. Marti, R.H. Wenger, L.A. Rivas, C. Bauer, and M. Gassmann. 1995. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. Natl. Acad. Sci. USA. 92:3717-3720. doi:10.1073/pnas.92.9.3717
13. Drueke, T.B., F. Locatelli, N. Clyne, K.U. Eckardt, I.C. Macdougall, D. Tsakiris, H.U. Burger, and A. Scherhag. 2006. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N. Engl. J. Med. 355:2071-2084. doi:10.1056/NEJMoa062276 (Pubitemid 44749316)
14. Fenjves, E.S., M.S. Ochoa, O. Cabrera, A.J. Mendez, N.S. Kenyon, L. Inverardi, and C. Ricordi. 2003. Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors. Transplantation. 75:1356-1360. doi:10.1097/01.TP.0000062862.88375.BD (Pubitemid 36513048)
15. Fenjves, E.S., M.S. Ochoa, C. Gay-Rabinstein, R.D. Molano, A. Pileggi, A.J. Mendez, L. Inverardi, and C. Ricordi. 2004. Adenoviral gene transfer of erythropoietin confers cytoprotection to isolated pancreatic islets. Transplantation. 77:13-18. doi:10.1097/01.TP.0000110422.27977.26 (Pubitemid 38116865)
16. Freemark, M., I. Avril, D. Fleenor, P. Driscoll, A. Petro, E. Opara, W. Kendall, J. Oden, S. Bridges, N. Binart, et al. 2002. Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. Endocrinology. 143:1378-1385. doi:10.1210/ en.143.4.1378
17. Fujinaka, Y., K. Takane, H. Yamashita, and R.C. Vasavada. 2007. Lactogens promote beta cell survival through JAK2/STAT5 activation and Bcl-XL upregulation. J. Biol. Chem. 282:30707-30717. doi:10.1074/jbc.M702607200 (Pubitemid 350035214)
18. Galeano, M., D. Altavilla, D. Cucinotta, G.T. Russo, M. Calo, A. Bitto, H. Marini, R. Marini, E.B. Adamo, P. Seminara, et al. 2004. Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes. 53:2509-2517. doi:10.2337/diabetes.53.9.2509 (Pubitemid 39145612)
19. He, T.-C., H. Zhuang, N. Jiang, M.D. Waterfield, and D.M. Wojchowski. 1993. Association of the p85 regulatory subunit of phosphatidylinositol 3-kinase with an essential erythropoietin receptor subdomain. Blood. 82:3530-3538.
20. Heeschen, C., A. Aicher, R. Lehmann, S. Fichtlscherer, M. Vasa, C. Urbich, C. Mildner-Rihm, H. Martin, A.M. Zeiher, and S. Dimmeler. 2003. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood. 102:1340-1346. doi:10.1182/blood-2003-01-0223 (Pubitemid 36988041)
21. Juul, S.E., A.E. Joyce, Y. Zhao, and D.J. Ledbetter. 1999. Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates. Pediatr. Res. 46:263-268. doi:10.1203/00006450-199909000-00003
22. Kahn, S.E. 2003. The relative contributions of insulin resistance and betacell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia. 46:3-19. doi:10.1007/s00125-002-1009-0
23. Krantz, S.B. 1991. Erythropoietin. Blood. 77:419-434.
24. Krishnamurthy, M., F. Ayazi, J. Li, A.W. Lyttle, M. Woods, Y. Wu, S.P. Yee, and R. Wang. 2007. c-Kit in early onset of diabetes: a morphological and functional analysis of pancreatic beta-cells in c-KitW-v mutant mice. Endocrinology. 148:5520-5530. doi:10.1210/en.2007-0387 (Pubitemid 350012638)
25. Kulkarni, R.N., U.S. Jhala, J.N. Winnay, S. Krajewski, M. Montminy, and C.R. Kahn. 2004. PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J. Clin. Invest. 114:828-836.
26. Lacombe, C., and P. Mayeux. 1998. Biology of erythropoietin. Haematologica. 83:724-732.
27. Lammert, E., G. Gu, M. McLaughlin, D. Brown, R. Brekken, L.C. Murtaugh, H.P. Gerber, N. Ferrara, and D.A. Melton. 2003. Role of VEGF-A in vascularization of pancreatic islets. Curr. Biol. 13:1070-1074. doi:10.1016/S0960-9822(03)00378-6 (Pubitemid 36726045)
28. Leverrier, Y., J. Thomas, A.L. Mathieu, W. Low, B. Blanquier, and J. Marvel. 1999. Role of PI3-kinase in Bcl-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells. Cell Death Differ 6:290-296. doi:10.1038/sj.cdd.4400492
29. Liadis, N., K. Murakami, M. Eweida, A.R. Elford, L. Sheu, H.Y. Gaisano, R. Hakem, P.S. Ohashi, and M. Woo. 2005. Caspase-3-dependent betacell apoptosis in the initiation of autoimmune diabetes mellitus. Mol. Cell. Biol. 25:3620-3629. doi:10.1128/MCB.25.9.3620-3629.2005 (Pubitemid 40559568)
30. Liadis, N., L. Salmena, E. Kwan, P. Tajmir, S.A. Schroer, A. Radziszewska, X. Li, L. Sheu, M. Eweida, S. Xu, et al. 2007. Distinct in vivo roles of caspase-8 in beta-cells in physiological and diabetes models. Diabetes. 56:2302-2311. doi:10.2337/db06-1771 (Pubitemid 47358237)
31. Like, A.A., and A.A. Rossini. 1976. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science. 193:415-417. doi:10 .1126/science.180605
32. Liu, J.L., K.T. Coschigano, K. Robertson, M. Lipsett, Y. Guo, J.J. Kopchick, U. Kumar, and Y.L. Liu. 2004. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am. J. Physiol. Endocrinol. Metab. 287:E405-E413. doi:10.1152/ajpendo. 00423.2003 (Pubitemid 39095873)
33. Mathis, D., L. Vence, and C. Benoist. 2001. ?-Cell death during progression to diabetes. Nature. 414:792-798. doi:10.1038/414792a (Pubitemid 34000782)
34. McGill, J.B., and D.S. Bell. 2006. Anemia and the role of erythropoietin in diabetes. J. Diabetes Complications. 20:262-272. doi:10.1016/ j.jdiacomp.2005.08.001 (Pubitemid 44202266)
35. Motoyama, N., F. Wang, K.A. Roth, H. Sawa, K. Nakayama, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, S. Fujii, et al. 1995. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science. 267:1506-1510. doi:10.1126/science.7878471
36. Neubauer, H., A. Cumano, M. Muller, H. Wu, U. Huffstadt, and K. Pfeffer. 1998. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell. 93:397-409. doi:10.1016/S0092-8674(00)81168-X (Pubitemid 28232084)
37. Nguyen, K.T., P. Tajmir, C.H. Lin, N. Liadis, X.D. Zhu, M. Eweida, G. Tolasa-Karaman, F. Cai, R. Wang, T. Kitamura, et al. 2006. Essential role of Pten in body size determination and pancreatic β-cell homeostasis in vivo. Mol. Cell. Biol. 26:4511-4518. doi:10.1128/MCB.00238-06 (Pubitemid 43877571)
38. Postic, C., M. Shiota, K.D. Niswender, T.L. Jetton, Y. Chen, J.M. Moates, K.D. Shelton, J. Lindner, A.D. Cherrington, and M.A. Magnuson. 1999. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274:305-315. doi:10.1074/jbc.274.1.305 (Pubitemid 29035064)
39. Quelle, F.W., D. Wang, T. Nosaka, W.E. Thierfelder, D. Stravopodis, Y. Weinstein, and J.N. Ihle. 1996. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 16:1622-1631.
40. Rhodes, C.J. 2005. Type 2 diabetes-a matter of β-cell life and death? Science. 307:380-384. doi:10.1126/science.1104345 (Pubitemid 40139973)
41. Ribatti, D., A. Vacca, A.M. Roccaro, E. Crivellato, and M. Presta. 2003. Erythropoietin as an angiogenic factor. Eur. J. Clin. Invest. 33:891-896. doi:10.1046/j.1365-2362.2003.01245.x (Pubitemid 37215045)
42. Savino, C., R. Pedotti, F. Baggi, F. Ubiali, B. Gallo, S. Nava, P. Bigini, S. Barbera, E. Fumagalli, T. Mennini, et al. 2006. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. J. Neuroimmunol. 172:27-37. doi:10.1016/j.jneuroim.2005.10.016 (Pubitemid 43279681)
43. Silva, M., A. Benito, C. Sanz, F. Prosper, D. Ekhterae, G. Nunez, and J.L. Fernandez-Luna. 1999. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. J. Biol. Chem. 274:22165-22169. doi:10.1074/jbc.274.32.22165 (Pubitemid 29379245)
44. Sorenson, R.L., and L.E. Stout. 1995. Prolactin receptors and JAK2 in islets of Langerhans: an immunohistochemical analysis. Endocrinology. 136:4092-4098. doi:10.1210/en.136.9.4092
45. Stiles, B.L., C. Kuralwalla-Martinez, W. Guo, C. Gregorian, Y. Wang, J. Tian, M.A. Magnuson, and H. Wu. 2006. Selective deletion of Pten in pancreatic beta cells leads to increased islet mass and resistance to STZ-induced diabetes. Mol. Cell. Biol. 26:2772-2781. doi:10.1128/ MCB.26.7.2772-2781.2006
46. Thomas, M.C. 2006. The high prevalence of anemia in diabetes is linked to functional erythropoietin deficiency. Semin. Nephrol. 26:275-282. doi:10.1016/j.semnephrol.2006.05.003 (Pubitemid 44754687)
47. Tiemann, K., R. Panienka, and G. Kloppel. 2007. Expression of transcription factors and precursor cell markers during regeneration of β cells in pancreata of rats treated with streptozotocin. Virchows Arch. 450:261-266. doi:10.1007/s00428-006-0349-4 (Pubitemid 46376556)
48. Tsai, P.T., J.J. Ohab, N. Kertesz, M. Groszer, C. Matter, J. Gao, X. Liu, H. Wu, and S.T. Carmichael. 2006. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J. Neurosci. 26:1269-1274. doi:10.1523/JNEUROSCI.4480-05.2006 (Pubitemid 43237059)
49. Umemura, T., K. Umene, H. Takahira, N. Takeichi, M. Katsuno, Y. Fukumaki, J. Nishimura, Y. Sakaki, and H. Ibayashi. 1988. Hematopoietic growth factors (BPA and Epo) induce the expressions of c-myc and c-fos proto-oncogenes in normal human erythroid progenitors. Leuk. Res. 12:187-194. doi:10.1016/0145-2126 (88)90135-X
50. Wagner, K.U., A. Krempler, A.A. Triplett, Y. Qi, N.M. George, J. Zhu, and H. Rui. 2004. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Mol. Cell. Biol. 24:5510-5520. doi:10.1128/MCB.24.12.5510-5520.2004 (Pubitemid 38738182)
51. Westenfelder, C., D.L. Biddle, and R.L. Baranowski. 1999. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int. 55:808-820. doi:10.1046/j.1523-1755.1999.055003808.x (Pubitemid 29100693)
52. Wijesekara, N., D. Konrad, M. Eweida, C. Jefferies, N. Liadis, A. Giacca, M. Crackower, A. Suzuki, T.W. Mak, C.R. Kahn, et al. 2005. Muscle-specific Pten deletion protects against insulin resistance and diabetes. Mol. Cell. Biol. 25:1135-1145. doi:10.1128/MCB.25.3.1135-1145.2005 (Pubitemid 40165819)
53. Wu, H., X. Liu, R. Jaenisch, and H.F. Lodish. 1995. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell. 83:59-67. doi:10 .1016/0092-8674(95)90234- 1
54. Yasuda, Y., S. Masuda, M. Chikuma, K. Inoue, M. Nagao, and R. Sasaki. 1998. Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J. Biol. Chem. 273:25381-25387. doi:10.1074/jbc.273.39.25381 (Pubitemid 28443305)